All Stories

  1. Therapeutic management of hyperlipoproteinemia (a)

    Article • Drugs in Context, September 2019, BioExcel

    Dr Gordon Mallarkey

  2. Cardiac myosin activators for heart failure therapy: focus on omecamtiv mecarbil

    Article • Drugs in Context, April 2018, BioExcel

    Dr Gordon Mallarkey

  3. European Society for Medical Oncology Copenhagen update: potential practice-changing findings

    Article • Therapeutic Advances in Medical Oncology, January 2017, SAGE Publications

    Dr Gordon Mallarkey

  4. Osteoporosis therapeutics: recent developments at ASBMR

    Article • Therapeutic Advances in Musculoskeletal Disease, January 2016, SAGE Publications

    Dr Gordon Mallarkey

  5. Latest therapeutic advances in musculoskeletal disease from the ACR 2015 annual conference

    Article • Therapeutic Advances in Musculoskeletal Disease, January 2016, SAGE Publications

    Dr Gordon Mallarkey, David Reid

  6. Targeting precision medicine toxicity: recent developments

    Article • Therapeutic Advances in Drug Safety, January 2015, SAGE Publications

    Dr Gordon Mallarkey

  7. Targeted therapies in medical oncology: successes, failures and next steps

    Article • Therapeutic Advances in Medical Oncology, January 2013, SAGE Publications

    Dr Gordon Mallarkey

  8. Pathways and biomarkers in breast cancer: latest evidence

    Article • Therapeutic Advances in Medical Oncology, June 2012, SAGE Publications

    Dr Gordon Mallarkey

  9. Latest drug safety alerts from the 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management

    Article • Therapeutic Advances in Drug Safety, February 2012, SAGE Publications

    Dr Gordon Mallarkey

  10. Latest advances in the medical treatment of cancer: a 2011 snapshot

    Article • Therapeutic Advances in Medical Oncology, November 2011, SAGE Publications

    Dr Gordon Mallarkey

  11. Advancing breast cancer therapy by translational research: highlights of the Improving Care and Knowledge through Translational Research (IMPAKT) breast cancer conference

    Article • Therapeutic Advances in Medical Oncology, July 2011, SAGE Publications

    Dr Gordon Mallarkey

  12. Latest advances in medical oncology: highlights from Milan ESMO 2010 annual congress

    Article • Therapeutic Advances in Medical Oncology, December 2010, SAGE Publications

    Dr Gordon Mallarkey

  13. Looking at the causes of, and possible treatments for, psychiatric diseases: gene–environment interactions, circadian rhythms and neuronal dysfunction

    Article • Therapeutic Advances in Chronic Disease, December 2010, SAGE Publications

    Dr Gordon Mallarkey

  14. Drug safety advances from ICPE 2010

    Article • Therapeutic Advances in Drug Safety, December 2010, SAGE Publications

    Dr Gordon Mallarkey

  15. Pharmacovigilance and pharmacogenetic discussions at WorldPharma 2010

    Article • Therapeutic Advances in Drug Safety, October 2010, SAGE Publications

    Dr Gordon Mallarkey

  16. Latest therapeutic advances from the ASCO 2010 Annual Meeting

    Article • Therapeutic Advances in Medical Oncology, July 2010, SAGE Publications

    Dr Gordon Mallarkey

  17. Highlights of the 2nd European Lung Cancer Conference

    Article • Therapeutic Advances in Medical Oncology, June 2010, SAGE Publications

    Dr Gordon Mallarkey

  18. Editorial: What are the therapeutic advances in gastroenterology? Opinions from world experts

    Article • Therapeutic Advances in Gastroenterology, September 2008, SAGE Publications

    Dr Gordon Mallarkey

  19. Review: Efficacy and safety of adalimumab in Crohn's disease

    Article • Therapeutic Advances in Gastroenterology, July 2008, SAGE Publications

    Dr Gordon Mallarkey

  20. What are the therapeutic advances in neurology? Opinions from world experts

    Article • Therapeutic Advances in Neurological Disorders, July 2008, SAGE Publications

    Dr Gordon Mallarkey

  21. An Evaluation of Eptacog Alfa in Nonhaemophiliac Conditions

    Article • Drugs, January 2008, Springer Science + Business Media

    Dr Gordon Mallarkey

  22. Esomeprazole

    Article • Drugs, January 2002, Springer Science + Business Media

    Dr Gordon Mallarkey

  23. Esomeprazole

    Article • Drugs, January 2002, Springer Science + Business Media

    Dr Gordon Mallarkey

  24. TPL3: BEST EVIDENCE IN PHARMACOECONOMICS

    Article • Value in Health, September 1999, Elsevier

    Dr Gordon Mallarkey

  25. A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea-pigs and rats

    Article • British Journal of Pharmacology, February 1985, Wiley

    Dr Gordon Mallarkey

  26. The effect of arachidonic acid metabolism on intravascular platelet aggregation in rats

    Article • Thrombosis Research, October 1984, Elsevier

    Dr Gordon Mallarkey

  27. Comparison of the actions of 11.9 epoxymethano PGH2 and 9.11 AZO PGH2 on rat aorta and stomach strip preparations

    Article • Prostaglandins, January 1984, Elsevier

    Dr Gordon Mallarkey

  28. In vivo platelet aggregation in the rat: dependence on extracellular divalent cation and inhibition by nonsteroidal anti-inflammatory drugs

    Article • British Journal of Pharmacology, January 1984, Wiley

    Dr Gordon Mallarkey

  29. A STUDY OF THE MECHANISM OF COLLAGEN-INDUCED INTRAVASCULAR PLATELET AGGREGATION IN THE RAT

    Article • Journal of Pharmacy and Pharmacology, December 1980, Wiley

    Dr Gordon Mallarkey